vs
Side-by-side financial comparison of Enhabit, Inc. (EHAB) and VIRTUS INVESTMENT PARTNERS, INC. (VRTS). Click either name above to swap in a different company.
Enhabit, Inc. is the larger business by last-quarter revenue ($270.4M vs $208.0M, roughly 1.3× VIRTUS INVESTMENT PARTNERS, INC.). VIRTUS INVESTMENT PARTNERS, INC. runs the higher net margin — 16.3% vs -14.3%, a 30.6% gap on every dollar of revenue. On growth, Enhabit, Inc. posted the faster year-over-year revenue change (4.7% vs -10.9%). Enhabit, Inc. produced more free cash flow last quarter ($3.3M vs $-74.1M). Over the past eight quarters, Enhabit, Inc.'s revenue compounded faster (1.5% CAGR vs -3.2%).
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
VIRTUS INVESTMENT PARTNERS, INC.VRTSEarnings & Financial Report
Virtus Investment Partners, Inc. is an American company which operates as a multi-manager asset management business, comprising a number of individual affiliated managers, each having its own investment process and brand, and the services of unaffiliated sub advisers.
EHAB vs VRTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.4M | $208.0M |
| Net Profit | $-38.7M | $33.9M |
| Gross Margin | — | — |
| Operating Margin | -12.3% | 19.1% |
| Net Margin | -14.3% | 16.3% |
| Revenue YoY | 4.7% | -10.9% |
| Net Profit YoY | 15.9% | -14.2% |
| EPS (diluted) | $-0.76 | $5.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.4M | $208.0M | ||
| Q3 25 | $263.6M | $216.4M | ||
| Q2 25 | $266.1M | $210.5M | ||
| Q1 25 | $259.9M | $217.9M | ||
| Q4 24 | $258.2M | $233.5M | ||
| Q3 24 | $253.6M | $227.0M | ||
| Q2 24 | $260.6M | $224.4M | ||
| Q1 24 | $262.4M | $222.0M |
| Q4 25 | $-38.7M | $33.9M | ||
| Q3 25 | $11.1M | $31.3M | ||
| Q2 25 | $5.2M | $42.7M | ||
| Q1 25 | $17.8M | $28.1M | ||
| Q4 24 | $-46.0M | $39.5M | ||
| Q3 24 | $-110.2M | $49.1M | ||
| Q2 24 | $-200.0K | $26.0M | ||
| Q1 24 | $200.0K | $37.9M |
| Q4 25 | -12.3% | 19.1% | ||
| Q3 25 | 6.4% | 21.7% | ||
| Q2 25 | 6.3% | 21.5% | ||
| Q1 25 | 6.1% | 16.8% | ||
| Q4 24 | -16.0% | 21.7% | ||
| Q3 24 | -38.6% | 24.3% | ||
| Q2 24 | 4.3% | 19.7% | ||
| Q1 24 | 4.9% | 14.5% |
| Q4 25 | -14.3% | 16.3% | ||
| Q3 25 | 4.2% | 14.5% | ||
| Q2 25 | 2.0% | 20.3% | ||
| Q1 25 | 6.8% | 12.9% | ||
| Q4 24 | -17.8% | 16.9% | ||
| Q3 24 | -43.5% | 21.6% | ||
| Q2 24 | -0.1% | 11.6% | ||
| Q1 24 | 0.1% | 17.1% |
| Q4 25 | $-0.76 | $5.15 | ||
| Q3 25 | $0.22 | $4.65 | ||
| Q2 25 | $0.10 | $6.12 | ||
| Q1 25 | $0.35 | $4.05 | ||
| Q4 24 | $-0.92 | $4.65 | ||
| Q3 24 | $-2.20 | $5.71 | ||
| Q2 24 | $0.00 | $2.43 | ||
| Q1 24 | $0.01 | $4.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.6M | — |
| Total DebtLower is stronger | $426.0M | $390.0M |
| Stockholders' EquityBook value | $534.0M | $934.0M |
| Total Assets | $1.2B | $4.3B |
| Debt / EquityLower = less leverage | 0.80× | 0.42× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.6M | — | ||
| Q3 25 | $56.9M | — | ||
| Q2 25 | $37.1M | — | ||
| Q1 25 | $39.5M | — | ||
| Q4 24 | $28.4M | — | ||
| Q3 24 | $45.7M | — | ||
| Q2 24 | $28.5M | — | ||
| Q1 24 | $36.5M | — |
| Q4 25 | $426.0M | $390.0M | ||
| Q3 25 | $441.5M | $390.6M | ||
| Q2 25 | $456.9M | $231.3M | ||
| Q1 25 | $467.3M | $231.7M | ||
| Q4 24 | $492.6M | $232.1M | ||
| Q3 24 | $502.9M | $237.5M | ||
| Q2 24 | $512.7M | $247.6M | ||
| Q1 24 | $526.7M | $253.0M |
| Q4 25 | $534.0M | $934.0M | ||
| Q3 25 | $566.8M | $918.7M | ||
| Q2 25 | $552.4M | $896.4M | ||
| Q1 25 | $543.2M | $893.7M | ||
| Q4 24 | $523.5M | $897.5M | ||
| Q3 24 | $566.1M | $889.0M | ||
| Q2 24 | $674.3M | $868.7M | ||
| Q1 24 | $672.3M | $871.7M |
| Q4 25 | $1.2B | $4.3B | ||
| Q3 25 | $1.2B | $3.9B | ||
| Q2 25 | $1.2B | $3.7B | ||
| Q1 25 | $1.2B | $3.7B | ||
| Q4 24 | $1.2B | $4.0B | ||
| Q3 24 | $1.3B | $3.6B | ||
| Q2 24 | $1.4B | $3.6B | ||
| Q1 24 | $1.4B | $3.5B |
| Q4 25 | 0.80× | 0.42× | ||
| Q3 25 | 0.78× | 0.43× | ||
| Q2 25 | 0.83× | 0.26× | ||
| Q1 25 | 0.86× | 0.26× | ||
| Q4 24 | 0.94× | 0.26× | ||
| Q3 24 | 0.89× | 0.27× | ||
| Q2 24 | 0.76× | 0.29× | ||
| Q1 24 | 0.78× | 0.29× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $-67.2M |
| Free Cash FlowOCF − Capex | $3.3M | $-74.1M |
| FCF MarginFCF / Revenue | 1.2% | -35.6% |
| Capex IntensityCapex / Revenue | 0.4% | 3.3% |
| Cash ConversionOCF / Net Profit | — | -1.99× |
| TTM Free Cash FlowTrailing 4 quarters | $65.8M | $100.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $-67.2M | ||
| Q3 25 | $37.8M | $108.3M | ||
| Q2 25 | $10.6M | $75.8M | ||
| Q1 25 | $17.9M | $-3.8M | ||
| Q4 24 | $-4.1M | $1.8M | ||
| Q3 24 | $28.4M | $69.1M | ||
| Q2 24 | $9.6M | $70.0M | ||
| Q1 24 | $17.3M | $-34.5M |
| Q4 25 | $3.3M | $-74.1M | ||
| Q3 25 | $36.2M | $106.9M | ||
| Q2 25 | $8.7M | $74.2M | ||
| Q1 25 | $17.6M | $-6.8M | ||
| Q4 24 | $-4.7M | $-3.8M | ||
| Q3 24 | $27.7M | $68.7M | ||
| Q2 24 | $8.9M | $68.6M | ||
| Q1 24 | $15.5M | $-36.5M |
| Q4 25 | 1.2% | -35.6% | ||
| Q3 25 | 13.7% | 49.4% | ||
| Q2 25 | 3.3% | 35.2% | ||
| Q1 25 | 6.8% | -3.1% | ||
| Q4 24 | -1.8% | -1.6% | ||
| Q3 24 | 10.9% | 30.3% | ||
| Q2 24 | 3.4% | 30.6% | ||
| Q1 24 | 5.9% | -16.4% |
| Q4 25 | 0.4% | 3.3% | ||
| Q3 25 | 0.6% | 0.7% | ||
| Q2 25 | 0.7% | 0.7% | ||
| Q1 25 | 0.1% | 1.4% | ||
| Q4 24 | 0.2% | 2.4% | ||
| Q3 24 | 0.3% | 0.2% | ||
| Q2 24 | 0.3% | 0.6% | ||
| Q1 24 | 0.7% | 0.9% |
| Q4 25 | — | -1.99× | ||
| Q3 25 | 3.41× | 3.45× | ||
| Q2 25 | 2.04× | 1.77× | ||
| Q1 25 | 1.01× | -0.13× | ||
| Q4 24 | — | 0.04× | ||
| Q3 24 | — | 1.41× | ||
| Q2 24 | — | 2.69× | ||
| Q1 24 | 86.50× | -0.91× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
VRTS
| Open End Funds | $68.9M | 33% |
| Retail Separate Accounts | $51.3M | 25% |
| Institutional Accounts | $39.6M | 19% |
| Administration And Shareholder Service Fees | $18.4M | 9% |
| Closed End Funds | $15.9M | 8% |
| Distribution And Service Fees | $12.3M | 6% |
